<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000045860">
  <TermName>rebeccamycin</TermName>
  <TermPronunciation>(reh-BEH-kuh-MY-sin)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called antineoplastic antibiotics.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000731249" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;rebeccamycin&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000731248" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;rebecamicina&quot;" language="es" id="_4"/>
  <SpanishTermName>rebecamicina</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento del cáncer. Pertenece al tipo de medicamentos llamados antibióticos antineoplásicos.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2005-01-20</DateLastModified>
</GlossaryTerm>
